The Munjal-Burmans further agreed to invest another Rs 1,000 crore via preferential issue of warrants priced at Rs 176 per share, it added. Of this Rs 250 crore will be upfront, being an amount equivalent to 25 per cent of the consideration of warrants at a price of Rs 176 per share, Fortis Healthcare Ltd said.
Reacting to the development, Sunil Kant Munjal said: "We are delighted that the board has accepted our offer, which is, unarguably, the best solution."
"We are sure that the shareholders will see the intrinsic value in our proposal and repose confidence in us. As long-term investors, we are committed to help make Fortis the finest healthcare institution in the region, and create value for all stakeholders," he added.
Anand Burman said that Fortis is a national healthcare asset which has a good spread across the country and hoped to help the company become what it ought to be. "Going forward, the immediate plan of action for the company should be to build on its strengths, retain talent, expand business and institutionalise processes at Fortis," he said.
The board also approved the appointment of Sabina Vaisoha and Rohit Bhasin as independent directors of the company for a period of five years from March 27 and April 19, 2018, respectively, it added.
